Send feedback

APOE p.Arg176Pro

c.527G>C · VCV4293341

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.8375 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
lipoprotein glomerulopathy

Computational evidence

Protein change
AlphaMissense0.8375likely pathogenic · top 3% in APOE
REVEL0.604indeterminate
SaProtLLR -10.16damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 6.9GERP 1.7, phastCons 1
Regional constrainto/e 1.02unconstrained · MANE · 2,622 bp · p 0.6 · regional, not allelic
Overall
CADD25.4PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene
APOE
Protein
p.Arg176Pro
Coding
c.527G>C
MANE Select
NM_000041
Type
single nucleotide variant
Location
chr19:44908823 (GRCh38)
Gene constraint
LOEUF 1.319 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 76.13 · 31 PDB
Residue 176
the '8 x 22 aa approximate tandem repeats' region; a UniProt-annotated variant site (in hlpp3; apoe2, apoe2 fukuoka, apoe1 weisgraber and apoe3**; apoe3** is associated with hlpp3; changed protein structure; decreased binding to ldlr and other lipoprotein receptors; decreased in vitro binding to heparin; no effect on distribution among plasma lipoproteins); an α-helix
Full APOE gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

lipoprotein glomerulopathy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Lipoprotein glomerulopathy (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Elderly
Prevalence
<1 / 1 000 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/apoe-p-arg176pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown